Ping An

Ping An Insurance (Group) Company of China, Ltd. is a comprehensive financial services provider established in 1988, headquartered in Shenzhen. The company operates across multiple sectors, including insurance, banking, asset management, and fintech, offering a wide range of products such as life, health, property, and casualty insurance, as well as banking services like loans and wealth management. Additionally, it engages in various investment activities through its venture capital arm, Ping An Capital, which focuses on early-stage investments in sectors such as technology, healthcare, and environmental protection. Ping An Capital aims to leverage the Group's extensive resources to support the growth of its portfolio companies, emphasizing green finance and ESG principles. The Group seeks to create an integrated financial services platform that enhances customer experience while promoting sustainable growth in profits and long-term returns to shareholders.

Ping Pong Academy

Charles Zhou

Head of Strategic Investment

122 past transactions

Soterea

Series B in 2022
Soterea mainly develops safe driving solutions and data service products for commercial vehicles.

Rain Med

Series D in 2021
Rain Med is a vascular interventional surgical robot developer focused on the development of coronary angiography systems.

Xgene Pharmaceutical

Series C in 2021
Xgene Pharmaceutical Inc. is a pharmaceutical company founded in 2015 and based in the Cayman Islands. The company specializes in the development of small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors. Through its research and development efforts, Xgene Pharmaceutical seeks to address significant medical needs in these areas.

Biren Technology

Series B in 2021
Shanghai Biren Intelligent Technology Co., Ltd. specializes in the design and manufacture of intelligent chips, focusing on advanced computing solutions. The company operates in both software and hardware sectors, bringing together top industry talents, including technical experts and elite engineers, to develop innovative products. Its hardware division is dedicated to creating versatile computing solutions, while the software department enhances these offerings with specialized applications. Additionally, the company maintains a research institute that investigates key technologies related to intelligent computing systems, emphasizing the development of new architectures and advanced compilation techniques. Through these efforts, Biren Technology aims to establish itself as a leading player in the high-tech sector.

Apollomics

Series C in 2020
Apollomics is a developer of oncology therapeutics intend to harness the immune system and targeting specific molecular pathways.The company's therapeutics target the growth and proliferation of cancer cells and offer an oral c-Met inhibitor that restores the body's immune system to recognize and kill cancer cells, enabling clients to treat their patients in an enhanced way.

Lepu Bio

Series B in 2020
Lepu Biotechnology Co., Ltd. is a China-based biotech company specializing in tumor immunotherapy. Founded in 2018, it has developed an industrial platform that facilitates the discovery, development, and manufacturing of innovative drug candidates. The company's core offerings include programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) antibodies, an oncolytic virus, and various antibody-drug conjugates (ADCs). These products have advanced into clinical stages I to III, highlighting the company's commitment to advancing cancer treatment through its proprietary technologies.

Wind

Funding Round in 2019
Wind Information is recognized as the leading firm in financial data, information services and solutions in China. We are dedicated to providing accurate and real-time data, as well as sophisticated information platforms for financial professionals.

Lixiangjia

Series D in 2019
The professional global Chinese overseas asset reconfiguration consulting service platform is dedicated to providing one-stop overseas asset product information support services for Chinese wealth management practitioners. It has set up branches in many cities across the country to provide institutions, financial planners and medium and high net worth families. Professional overseas asset reconfiguration plan.

Shijiazhuang Junlebao Dairy

Funding Round in 2019
Shijiazhuang Junlebao Dairy is operates as a dairy products company. The Company sells fluid milks, milk powder, and related products.

iTutorGroup

Acquisition in 2019
ITutorGroup provides online education platforms for students and business professionals. Its products include VIPABC, TutorABC, VIPABCJr, and TutorABCJr for English-language learning, TutorMing for Mandarin Chinese language learning, and LiveH2H for live translations in multiple languages. Eric Yang, Jerry Huang, and Ming Yang founded ITutorGroup in 1998, with headquarters in Taipei City in Taiwan. It has additional offices in Shanghai in China and Santa Clara in California.
Lenovo Healthcare is a cloud-based smart medical solution company for medical institutions.
Global Data Solutions Limited owns and operates data centers. The company also provides information technology outsourcing services in the Asia-Pacific region. The company offers business continuity and disaster recovery services that include planning, design, implementation, and operation; test center services; data center platform services; and ECC operation and monitoring. It serves government agencies and industries, which include finance, energy, manufacturing, and aviation. Global Data Solutions Limited was formerly known as First Asia Data Corporation. The company was founded in 2000 and is based in Beijing, China. It has data centers in Beijing, Shanghai, Chengdu, Shenzhen, Kunshan, and Guangzhou, China.

Zhangshang Tangyi

Series C in 2019
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.

Xiaoqule

Series A in 2018
Xiaoqule (Happy Community) is a Chinese community-focused e-commerce platform. It is a subsidiary of Gejia. Xiaoqule helps local businesses provide cost-effective products and services to the local community. On the platform, the consumer can order food such as seasonal fruits and vegetables from local businesses. Xiaoqule connects local businesses with local consumers, which shortens transportation time and maintains quality of goods. Xiaoqule also serves as a logistical company, providing transportation, technology, marketing and customer support.

Global Scanner

Series A in 2018
Global Scanner is provider of imported food products.

NextCure

Series B in 2018
NextCure, Inc. is a clinical-stage biopharmaceutical company based in Beltsville, Maryland, dedicated to discovering and developing innovative immunomedicines for cancer and other immune-related diseases. The company’s lead product candidate, NC318, is currently undergoing Phase 2 clinical trials aimed at treating advanced or metastatic solid tumors. Additionally, NextCure is advancing NC410, an immunomedicine designed to counteract immune suppression through targeting an immune modulator known as Leukocyte-Associated Immunoglobulin-like Receptor 1. The company is also engaged in research programs evaluating novel immunomodulatory molecules, including antibodies in preclinical development that target specific immune modulators in inflamed tissues and tumor microenvironments. NextCure has established a license agreement with Yale University and collaborates with Eli Lilly and Company for research and development efforts. Founded in 2015, the company leverages proprietary platforms to identify biologically relevant targets and develop first-in-class immunotherapy products.

Xgene Pharmaceutical

Series B in 2018
Xgene Pharmaceutical Inc. is a pharmaceutical company founded in 2015 and based in the Cayman Islands. The company specializes in the development of small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors. Through its research and development efforts, Xgene Pharmaceutical seeks to address significant medical needs in these areas.
Lenovo Healthcare is a cloud-based smart medical solution company for medical institutions.
Jin Jiang Environmental Holdings Limited is China's leading waste to energy operators.The company has successfully embarked on a road of environmentally-friendly energy industrialization that combines production, learning

Grab

Series H in 2018
Grab Holdings Inc. is a Singapore-based company that offers a comprehensive mobile technology platform providing various online-to-offline services in Southeast Asia. Founded in 2012 by Anthony Tan and Tan Hooi Lng, Grab operates in several countries, including Singapore, Indonesia, the Philippines, Malaysia, Thailand, Vietnam, and Myanmar. The platform includes a wide range of services such as transportation options like GrabTaxi and GrabCar, and delivery services, alongside solutions for financial transactions through Grab Financial Group. This group provides services in payments, rewards, lending, and insurance, and features a user-friendly point-of-sale system for merchants, as well as a mobile wallet for convenient transactions. Grab aims to enhance the quality of life for its users by integrating essential services into a single app.

Grab

Series H in 2018
Grab Holdings Inc. is a Singapore-based company that offers a comprehensive mobile technology platform providing various online-to-offline services in Southeast Asia. Founded in 2012 by Anthony Tan and Tan Hooi Lng, Grab operates in several countries, including Singapore, Indonesia, the Philippines, Malaysia, Thailand, Vietnam, and Myanmar. The platform includes a wide range of services such as transportation options like GrabTaxi and GrabCar, and delivery services, alongside solutions for financial transactions through Grab Financial Group. This group provides services in payments, rewards, lending, and insurance, and features a user-friendly point-of-sale system for merchants, as well as a mobile wallet for convenient transactions. Grab aims to enhance the quality of life for its users by integrating essential services into a single app.

Grab

Series H in 2018
Grab Holdings Inc. is a Singapore-based company that offers a comprehensive mobile technology platform providing various online-to-offline services in Southeast Asia. Founded in 2012 by Anthony Tan and Tan Hooi Lng, Grab operates in several countries, including Singapore, Indonesia, the Philippines, Malaysia, Thailand, Vietnam, and Myanmar. The platform includes a wide range of services such as transportation options like GrabTaxi and GrabCar, and delivery services, alongside solutions for financial transactions through Grab Financial Group. This group provides services in payments, rewards, lending, and insurance, and features a user-friendly point-of-sale system for merchants, as well as a mobile wallet for convenient transactions. Grab aims to enhance the quality of life for its users by integrating essential services into a single app.

Chemclin

Private Equity Round in 2018
Beijing Chemclin Biotech Co., Ltd. specializes in the development of diagnostic reagents and in-vitro diagnostic instruments. Founded in 1999 and based in Beijing, China, the company offers a range of products for clinical diagnosis, including reagents for infectious diseases and tumor markers. Chemclin is known for its Chemclin100, a semi-automated chemiluminescent analyzer, and the Chemclin600, a fully automated chemiluminescent system designed for conducting assays on micro-titer plates. Additionally, Chemclin provides commercial testing services for various health conditions such as infectious diseases, tumors, thyroid issues, diabetes, fertility, and liver fibrosis. The company also offers technical services, management, certification, and operates independent medical laboratories, focusing on introducing innovative diagnostic products and services to the Chinese healthcare market.

Jollychic

Series C in 2018
Jollychic EC Limited is an online retail platform that offers a diverse range of products, including clothing, shoes, bags, baby items, electronics, home goods, and various accessories. Established in 2012 and headquartered in Birkirkara, Malta, Jollychic aims to provide customers with a convenient shopping experience through its extensive selection of stylish and quality products. The platform features categories such as apparel, sports goods, toys, bedding, wedding supplies, cleaning tools, and kitchen appliances, making it a comprehensive destination for consumers seeking a variety of goods in one place.

Tmunity Therapeutics

Series A in 2018
Tmunity Therapeutics, Inc. is a bio-therapeutics company based in Philadelphia, Pennsylvania, focused on developing innovative immunotherapies for cancer, infectious diseases, and autoimmune disorders. Founded in 2015, the company specializes in harnessing the potential of T cells through the creation of novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. These products are designed to provide superior control over T cell activation and direction in vivo. Tmunity employs proprietary technologies for the activation, expansion, and genetic engineering of T cells derived from peripheral blood, cord blood, and tumors. The company's expert founding team has extensive experience in T-cell biology, manufacturing, regulatory affairs, and clinical development, enabling them to efficiently advance personalized next-generation immunotherapies into clinical trials. Tmunity's robust manufacturing platform has demonstrated success in supporting multi-center clinical studies across a variety of therapeutic areas.

Hua Medicine

Series D in 2018
Hua Medicine is a clinical-stage, innovative drug development company in China, focused on novel therapies for the treatment of diabetes and CNS disorders. Founded by pharma industry veterans and funded by a premier group of international VC investment firms such as Fidelity Asia, Fidelity Biosciences, ARCH Ventures, Venrock, SAIL and WuXi Ventures, the company has in-licensed from major pharma, world-wide rights to a potential best-in-class, oral drug for the treatment of Type 2 Diabetes which utilizes a novel mechanism of action.

Rani Therapeutics

Venture Round in 2018
Rani Therapeutics develops an oral biotherapeutics technology for the oral delivery of large drug molecules, including peptides, proteins, and antibodies. The company was founded in 2012 and is based in San Jose, California.

TytoCare

Series C in 2018
TytoCare Ltd. develops handheld devices and application that connects people with doctor for an on-demand medical exam, diagnosis, and prescription if needed, anytime, and anywhere. The company’s tools help in examining the heart, lungs, skin, ears, throat, abdomen, and body temperature, and diagnose and treat various common conditions, such as ear infections, cold and flu, fever, headaches, eye irritation, congestion, sinus pain, allergies, sore throat, coughs and upper respiratory issues, bug bites and rashes, constipation, and stomachaches. TytoCare Ltd. has a strategic partnership with Novant Health. The company was incorporated in 2011 and is based in Netanya, Israel with an additional office in New York, New York.

Tmunity Therapeutics

Series A in 2018
Tmunity Therapeutics, Inc. is a bio-therapeutics company based in Philadelphia, Pennsylvania, focused on developing innovative immunotherapies for cancer, infectious diseases, and autoimmune disorders. Founded in 2015, the company specializes in harnessing the potential of T cells through the creation of novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. These products are designed to provide superior control over T cell activation and direction in vivo. Tmunity employs proprietary technologies for the activation, expansion, and genetic engineering of T cells derived from peripheral blood, cord blood, and tumors. The company's expert founding team has extensive experience in T-cell biology, manufacturing, regulatory affairs, and clinical development, enabling them to efficiently advance personalized next-generation immunotherapies into clinical trials. Tmunity's robust manufacturing platform has demonstrated success in supporting multi-center clinical studies across a variety of therapeutic areas.

KBP Biosciences

Series A in 2018
KBP Biosciences Co., Ltd. is a biotechnology company based in Jinan, China, with additional offices in Beijing, Japan, and the United States. Founded in 2002, the company focuses on the research and development of drugs targeting infectious and metabolic diseases. Its comprehensive research platform employs structure-based drug design, in vitro and cell-based biological screening, and pharmacodynamic and pharmacokinetic evaluation, alongside ADME profiling and pre-clinical animal pharmacology and toxicity analysis. KBP Biosciences also offers services related to the transfer of new drugs, licensing, and intellectual property protection, which includes patent scope analysis, novelty analysis, and patent writing and filing. The organization is committed to delivering innovative therapies to address unmet medical needs.

Startup Health

Venture Round in 2018
StartUp Health is investing in a global army of Health Transformers to achieve health moonshots. StartUp Health is on a 30-year mission to collaborate with entrepreneurs to improve the health and wellbeing of everyone in the world. Since 2011, StartUp Health has been investing in a global army of entrepreneurs -- called Health Transformers -- to achieve health moonshots: Access to Care, Cost to Zero, Cure Disease, End to Cancer, Women’s Health, Children’s Health, Nutrition and Fitness, Brain Health, Mental Health and Happiness, Addiction, Longevity, and Pandemic Response. StartUp Health has the world’s largest health innovation portfolio with more than 330 companies across six continents and 26 countries and is backed by leading investors including Advocate Aurora Health, Chiesi, Steve Case, Mark Cuban, Esther Dyson, Brad Feld, GuideWell, Jason Finger, Jerry Levin, Kaiser Permanente, Masimo, Novartis, Otsuka, and Ping An.

Rogrand

Series C in 2017
Beijing Rogrand E-Commerce Co., Ltd. is a leading pharmaceutical entire integration of industry chain service platform in China leading the innovation of new pharmaceutical business model. Since its inception in 2012, the company has always been driven by the goal of forging a circulation platform for the whole industry consisting of pharmaceutical industry, pharmaceutical business, pharmacy, clinic and medical institution.

Chexiang

Series B in 2017
Chexiang is a Chinese online-to-offline automotive trading platform operated by Shanghai-based SAIC Motor Co. Ltd. The platform is designed to serve the automotive needs of consumers in China, offering services that include renting, buying, sharing, or booking vehicles at competitive prices. By facilitating these transactions, Chexiang aims to enhance the travel experience for its users, providing convenient access to various automotive options.

Fullerton Health

Venture Round in 2017
Fullerton Health is a leading provider of corporate healthcare solutions across Asia Pacific with more than 225 fully-owned medical centres, a network of more than 8,000 medical providers, 2,000 employees including more than 1,200 healthcare professionals, and six call centres across five countries.

Tikin Media

Angel Round in 2017
Tikin Media is a forward-looking advertising company that innovates building elevator media. The shareholders are composed of the world's top 500 and well-known media groups. They were successively invested by Baidu Venture Capital, Sequoia China and IDG within one year. Since its inception, the company has positioned itself to be a “high-end commercial building effect media operator”. The company's self-developed and possessed intellectual property elevator projection equipment is a new media form that subverts existing planar communication media, realizes mobile interconnection, and has programmatic ordering and big data analysis functions.

Annoroad

Series C in 2017
Annoroad Gene Technology Co. Ltd. provides clinical cytogenetic medical testing services for the development of a new genomics technology. The company was founded in 2012 and is based in Beijing, China.

Huya

Series A in 2017
Guangzhou Huya Information Technology Co., Ltd. is a leading interactive broadcast platform in China, primarily focused on game live streaming. Established in 2011 and headquartered in Guangzhou, the company offers a diverse range of livestreamed content, including esports, mobile, PC, and console games, as well as various entertainment genres such as talent shows, anime, and outdoor activities. Huya operates its main platform in China and also runs Nimo TV, which caters to audiences in Southeast Asia and Latin America. The platform features nearly 300 channels and covers approximately 3,800 games, allowing for real-time interaction between broadcasters and viewers. In addition to live streaming, Huya provides online advertising, marketing services, and software development. As of 2023, Huya is a subsidiary of Tencent Holdings, which holds a majority stake in the company.

Aiqi Technology

Series A in 2017
Beijing AIQI Technology Co., Ltd. is an Internet technology company founded in 2013 and based in Beijing, China. The company specializes in the research and development of artificial intelligence and robotic technology, focusing on the creation of DIY intelligent robots. AIQI has developed a range of interactive robots aimed at K-12 STEM education, promoting human-machine interaction and creativity among users. In recent years, the company has secured numerous patents in intelligent equipment and established a partnership with the technology giant Xiaomi, becoming the sole provider of DIY intelligent robots within Xiaomi's ecosystem. With a strong research team and advanced production capabilities, AIQI Technology aims to deliver innovative and user-friendly robotic solutions that enhance modern life.

Global Switch

Secondary Market in 2016
Global Switch Holdings Limited owns, develops, and operates data centers in Europe and the Asia-Pacific. Its properties include a portfolio of thirteen network dense, carrier, and cloud neutral multi-tenanted data centers offering approximately 390,000 square meters of technical space. The company’s data centers provide technical space, power and cooling, security, and infrastructure and environmental monitoring services for its customers to house their computer servers, network equipment, and information technology infrastructure. It also owns and operates real estate properties. Global Switch Holdings Limited was founded in 1998 and is based in London, the United Kingdom.

Taptap

Series A in 2016
TapTap is a community game, is also a platform game download purchase.

Innovent Biologics

Series D in 2016
Innovent Biologics, Inc. is a prominent biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacture, and commercialization of monoclonal antibody drug candidates. The company focuses on various therapeutic areas, including oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody used in treating multiple cancers and is featured on the National Reimbursement Drug List. Innovent has developed several other promising candidates, including biosimilars and bispecific antibodies for conditions such as non-Hodgkin’s lymphoma, autoimmune diseases, and advanced solid tumors. The company has established strategic collaborations with major global pharmaceutical firms, enhancing its research and development capabilities. Founded in 2011, Innovent has a strong management team with extensive experience in biologics, and it continues to expand its portfolio of therapeutic options while maintaining a commitment to innovation in the biopharmaceutical industry.

Gegejia.com

Series A in 2016
Gege home, under the Zhejiang Grid Network Technology Co., Ltd., focused on imported food sales, on-line time March 26, 2015, on-line orders within 30 days more than 10,000 single orders for millions of dollars. Gege home core team all have 5 years to 10 years of e-commerce-related experience, and a strong accumulation of industry resources.

Nanopep

Seed Round in 2016
Nanoprep, a nano-biotech company, engages in research and development of products and services of precision medical technology for cancer treatment and prevention. The company is based in Beijing, China.
Fabric Genomics is making genomics-driven precision medicine a reality. We provide clinical decision support software that enables clinical labs, hospital systems and country-sequencing programs to gain actionable genomic insights, resulting in faster and more accurate diagnoses and reduced turnaround time. Fabric’s end-to-end genomic analysis platform incorporates proven AI algorithms, and has applications in both hereditary disease and oncology. Headquartered in Oakland, California, Fabric Genomics was founded by industry veterans and innovators with a deep understanding of bioinformatics, large-scale genomics and clinical diagnostics.

Applied StemCell

Series D in 2016
Applied StemCell Inc. (ASC) is a fast growing biotechnology company providing animal and cell line models as tools for drug discovery and diagnostics. Using our proprietary TARGATT™ gene modification technology, we make site-specific Knockin mouse, rat and human cell line models fast and efficient for pharmaceutical and academic community. Based on our Proprietary Technologies, we focus on the development and commercialization of: Mouse models (Knockin, Knockout, Transgenic, Site-specific transgenic - TARGATT™, Humanized mouse models) Rat models Human cell line model (Gene modified iPSC - adult stem cell / progenitor cells - differentiated cells) Stem cell culture products (optimized stem cell medium and reporters) Gene engineering in stem cells or other mammalian cells (e.g. generation of protein - production mammalian cell lines) We are striving to improve and expand our technologies and product lines to meet the increasing requirements of biomedical community. ASC welcomes your comments, suggestions and ideas.

Rogrand

Series B in 2016
Beijing Rogrand E-Commerce Co., Ltd. is a leading pharmaceutical entire integration of industry chain service platform in China leading the innovation of new pharmaceutical business model. Since its inception in 2012, the company has always been driven by the goal of forging a circulation platform for the whole industry consisting of pharmaceutical industry, pharmaceutical business, pharmacy, clinic and medical institution.

F-ROAD

Series E in 2016
Shanghai F-road Commercial Services Co., Ltd. provides mobile financial services for financial institutions. The company offers a range of services, including encrypted mobile banking services, online day-to-day services, development and operation of community bank, asset management of regional banks, and Internet finance; and mobile banking solutions to regional banks. It offers its services through mobile terminals. Shanghai F-Road Commercial Services Co., Ltd. was founded in 2008 and is based in Shanghai, China.

Autohome

Acquisition in 2016
Autohome Inc. is the leading online destination for automobile consumers in China. Through their two websites, autohome.com.cn and che168.com, they provide comprehensive, independent and interactive content to automobile buyers and owners. Autohome.com.cn ranked first among China's automotive websites and automotive channels of internet portals in terms of average daily unique visitors, average daily time spent per user and average daily page views in 2013, according to iResearch, a third-party research firm. Their ability to reach a large and engaged user base of automobile consumers have made them the preferred platform for automakers and dealers to conduct their advertising campaigns. Automakers typically utilize their advertising services for brand promotion, new model releases and sales promotions. Their dealer subscription services allow dealers to market their inventory and services through their websites, extending the reach of their physical showrooms to potentially millions of internet users in China.

Prenetics

Series A in 2016
Prenetics is a genetic and diagnostic health testing company that leverages DNA sequencing technology to help individuals identify health risks. Founded in 2009 and headquartered in Quarry Bay, Hong Kong, Prenetics empowers users with insights into how their genetics influence diet, drug responses, and disease risks, enabling proactive health management. The company operates two primary brands, CircleDNA in Asia and DNAFit, offering services such as a digital coaching app and the ONEdna screening test, which provides actionable recommendations based on genetic analysis. Additionally, Prenetics specializes in pharmacogenomics through its iGenes PGx test, which aids healthcare providers in determining the most suitable medications and dosages for patients based on their genetic profiles, particularly for cardiovascular and psychiatric conditions. The company has formed strategic partnerships with The Lippo Group and New Horizon Health Limited.

Fe3 Medical

Series B in 2016
Fe3 Medical, Inc., operating as Bria Medical, specializes in developing transdermal therapies specifically for iron deficiency anemia. The company has created a disposable transdermal patch designed to deliver about 10 milligrams of iron directly through the skin, effectively bypassing the gastrointestinal tract and minimizing side effects commonly associated with oral iron supplements. Primarily targeting women, Fe3 Medical aims to provide a safe and non-toxic alternative for those affected by iron deficiency. Established in 2008, the company is headquartered in San Antonio, Texas.

JMDNA

Series B in 2016
JMDNA (Shanghai) Bio-Medical Technology Co., Ltd. engages in research and application services of molecular diagnosis. The company was founded in 2011 and is based in Shanghai, China.

Oscar Health

Private Equity Round in 2016
Oscar Health is a health insurance company that provides individual and family plans, Medicare Advantage, and small group products. Founded in 2012 and headquartered in New York, Oscar Health operates in several states, including New York, Texas, California, New Jersey, Ohio, and Tennessee. The company aims to enhance the healthcare experience by utilizing technology, design, and data to create user-friendly services. Its platform includes a software application that helps users find doctors based on location and ratings. Oscar Health primarily serves individuals and families who do not receive health insurance from their employers.

20/20 Gene Systems

Series A in 2016
20/20 GeneSystems (‘20/20’) was founded in May of 2000 to develop and promote an innovative proteomics product line that provides drug companies, biodefense specialists and life scientists with new tools for protein analysis. Their headquarters are in the heart of the biotechnology corridor in Rockville, Maryland in close proximity to the National Institutes of Health with which they have extensive collaborations. 20/20 GeneSystems develops and commercializes innovative, proprietary diagnostics tests that aid in the fight against cancer. These tests generally fall into three categories: - Personalized Medicine: Their patented platform technology for measuring biomarkers in tumors is highly unique in that it combines the visual advantages of classical pathology with the multiplex capabilities needed as a result of genomics and proteomics. This technology is now being used to develop tests to predict responses to several new targeted therapies for kidney and lung cancer. - Early detection of lung cancer: 20/20 is developing a blood test for the early detection of lung cancer. This product will be used for screening smokers and former smokers to pre-select or enrich the patient population to receive annual CT scanning long before the disease becomes symptomatic. - Biological Detection: 20/20 is on the leading edge of developing technologies to help in the detection of biological toxins.

Zhangshang Tangyi

Series B in 2016
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.

Alchemy Information

Angel Round in 2015
Provider of game art outsourcing services intended for game development companies. The company specializes in game art production and animation production for various game platforms, committed to providing self-developed high-quality game entertainment products for the global market.

MOGU

Series E in 2015
MOGU is an consumer platform aimed towards women, achieved through e-commerce, social media, influencers and content driven services. Their content covers all areas of the fashion world and they have a huge range of age groups and interest covered through their numerous apps and platform. MOGU Inc. is a destination of fashion. With various kinds of fashion content and abundant fashion products, MOGU Inc. allows people to discover and share fashion trends while fully enjoying high-quality shopping experience. In 2011, MOGU Inc. launched fashion platform under the Mogujie brand . In 2016, the merger of Mogujie and Meilishuo was completed.Currently, MOGU Inc.'s online platform includes Mogujie.com and Meilishuo.com websites, mogujie mobile app, Meilishuo mobile app, Uni mobile app and several WeChat Mini programs.

Anxin Doctor

Series A in 2015
Anxin Doctor is a mobile maternal and pediatric health platform that connects patients with obstetrics, gynecology doctors and pediatrics doctors.

Zhangshang Tangyi

Series A in 2015
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.

58 Daojia

Series A in 2015
The company provides information on and access to high-quality offline services such as cleaning, moving, babysitting, beauty care, and many other categories in approximately 30 cities in China. With its location-based order processing system, 58 Home's platform directly connects customers to the nearest independent service providers. Founded in September 2014, 58 Home is a multi-category local services platform in China.

Clinicloud

Seed Round in 2015
CliniCloud, Inc. develops a connected medical kit that enables users to monitor fever, chill, cough, wheeze, or cold. Its application also provides metrics, such as respiratory rate and heart rate to help users to see if anything is out of the ordinary. The company is based in San Francisco, California.

Ativa Medical

Series B in 2015
Ativa Medical Corporation is a medical device manufacturing company focused on developing and commercializing point of care testing diagnostic products tailored for decentralized healthcare settings. Founded in 2008 and headquartered in Saint Paul, Minnesota, the company specializes in providing analyzers that conduct essential hematology and clinical chemistry tests, along with disposable test cards designed for trauma, pediatric, oncology, and geriatric patients. Ativa Medical aims to deliver diagnostic test results in moments rather than hours or days, serving a diverse range of clients, including hospital departments, physician's offices, and remote healthcare clinics across the globe.

Payoneer

Series E in 2015
Payoneer Inc. operates a cross-border payments platform designed to facilitate global commerce by connecting businesses, professionals, countries, and currencies. Founded in 2005 and headquartered in New York, the company offers products such as the Global Payment Service, which provides users with local receiving accounts in the United States, European Union, and Japan, allowing for direct local bank transfers. Additionally, Payoneer enables users to receive payments from various integrated partners, including those in freelance, e-commerce, and online advertising sectors. The company also provides mass payout services that assist Indian companies in transferring funds internationally. Serving millions of users across over 200 countries, Payoneer is a trusted partner for numerous prominent corporations, making cross-border payments as straightforward as local transactions.
Beijing Express Channel Cold Chain Logistics Co., Ltd. is based in Beijing, China.

Secoo

Series E in 2015
Secoo is a Chinese comprehensive luxury products- and services-based platform. Secoo assists buyers and suppliers all over the world in doing business by setting up offline stores and an online mall to serve customers directly. The company plans to establish a series of exhibition centers in Beijing, Shanghai, Hong Kong, etc. The company turned over a hundred million of RMB in 2011 and has 500 thousand of members around the world including more than 20 thousand VIPs. At the end of 2010 Secoo won a $10M investment from IDG, followed by a $30M investment from Top 4 International Funds.

Didi

Private Equity Round in 2015
Didi Chuxing is a mobile transportation platform that offers app-based transportation services. The company offers a mobile tech-based mobility option for users across, including taxi hailing, private car-hailing, Hitch (social ride-sharing), DiDi Chauffeur, DiDi Bus, DiDi Test Drive, DiDi Car Rental, and DiDi Enterprise Solutions. As a practitioner in the sharing economy initiative, DiDi is committed to working with communities and partners to solve transportation, environmental challenges, and employment problems using big data-driven deep-learning algorithms that optimize resource allocation. Bo Zhang and Wei Cheng established the company in 2012 in Beijing, Beijing.

Rogrand

Series A in 2015
Beijing Rogrand E-Commerce Co., Ltd. is a leading pharmaceutical entire integration of industry chain service platform in China leading the innovation of new pharmaceutical business model. Since its inception in 2012, the company has always been driven by the goal of forging a circulation platform for the whole industry consisting of pharmaceutical industry, pharmaceutical business, pharmacy, clinic and medical institution.

Medbanks

Series A in 2015
Medbanks Network Technology Co. Ltd. provides data processing services to healthcare industry. The company develops multi center database that manages and mines data that reflects China's patient population. Medbanks Network Technology Co. Ltd. was founded in 2014 and is based in Beijing, China.

eXiche

Series A in 2015
eXiche provide users with Internet booking to the shop car wash, door car wash services.

9F Group

Series B in 2015
9F Fintech Holdings Group is a Chinese Fintech platform and has more than 68 million registered users with most of them using 9F’s mobile applications. Founded in 2006, 9F is committed to offering its users with simple, efficient, high-quality and comprehensive financial services and aimed to create a wealth of values for its users through mobile Internet and Big Data risk management technologies. With its many brands such as 9F Onecard, 9F Wallet, Wukong Wealth, 9F Primasia Securities, 9FChaoneng (3C at POS), LabiFenqi (Education), and Wecash, 9F Group offers an extensive range of services that cover the various needs of its member life stages. In addition, through "Jiuchuang Fund," 9F has invested into over ten Internet finance start-ups to explore future technologies and developments. 9F was a founding member of National Internet Finance Association of China (NIFA) and elected to be a board member of NIFA. Sponsored by the People’s Bank of China, the China Banking Regulatory Commission (CBRC), China Securities Regulatory Commission (CSRC) and China Insurance Regulatory Commission (CIRC), NIFA was founded in Shanghai in March 2016.

Rainbow Medical

Venture Round in 2015
Rainbow Medical is a unique private operational company that seeds and grows companies developing breakthrough medical devices invented by Yossi Gross in a diverse range of medical fields. By addressing significant unmet market needs, Rainbow Medical seeks to generate exceptional returns for its investors.

Wanjianglong

Series A in 2015
Wuhan Wanjianglong Network Co., Ltd. designs and develops digital consumer service platform for business and shopping centers. The company's platform provides services including commercial center platform construction, back-end big data management, big data back-office intelligent operation, and marketing. The company was incorporated in 2014 and is based in Wuhan, China.

Mogoroom

Series A in 2014
Mogoroom currently operates in Shanghai and Beijing, providing standardized rental apartments to young professionals seeking more convenient living environment services.

eToro

Series D in 2014
eToro is a social trading investment network that facilitates financial trading by allowing users to observe and replicate the trading activities of others. Established in 2007 and headquartered in London, the platform aims to democratize access to global markets by providing tools for both manual and automated trading across various asset classes, including traditional investments and cryptocurrencies. Its key features include the OpenBook and WebTrader platforms, which enable users to share live trading insights and learn from one another. eToro's model fosters a collaborative environment where investors can leverage the expertise of their peers while making informed trading decisions. The company also maintains registered offices in Cyprus and Israel, operating as a subsidiary of eToro Group Limited.

Payoneer

Series D in 2014
Payoneer Inc. operates a cross-border payments platform designed to facilitate global commerce by connecting businesses, professionals, countries, and currencies. Founded in 2005 and headquartered in New York, the company offers products such as the Global Payment Service, which provides users with local receiving accounts in the United States, European Union, and Japan, allowing for direct local bank transfers. Additionally, Payoneer enables users to receive payments from various integrated partners, including those in freelance, e-commerce, and online advertising sectors. The company also provides mass payout services that assist Indian companies in transferring funds internationally. Serving millions of users across over 200 countries, Payoneer is a trusted partner for numerous prominent corporations, making cross-border payments as straightforward as local transactions.

JMDNA

Series A in 2014
JMDNA (Shanghai) Bio-Medical Technology Co., Ltd. engages in research and application services of molecular diagnosis. The company was founded in 2011 and is based in Shanghai, China.

Mogoroom

Series A in 2014
Mogoroom currently operates in Shanghai and Beijing, providing standardized rental apartments to young professionals seeking more convenient living environment services.